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  Laboratory evaluation and interpretation of haemostasis in small animals
Mischke R.
Small Animal Clinic, University of Veterinary Medicine Hannover, Bünteweg 9, D-30559 Hannover, Germany
   Η εργαστηριακή διερεύνηση της αιμόστασης στα ζώα συντροφιάς
Mischke R.
Small Animal Clinic, University of Veterinary Medicine Hannover, Bünteweg 9, D-30559 Hannover, Germany
AbstRAct
This review deals with indications for performing haemostasis tests, methodical aspects of blood sampling and handling of 
sample material, selection of appropriate tests and basic principles of test interpretation. Indications for laboratory evaluation of 
haemostasis in small animals include spontaneous bleeding or bleeding disproportionate to the degree of trauma, bleeding from 
multiple sites and diseases which are frequently associated with haemostatic disorders. Patient history and clinical findings can 
deliver clues  for the type of haemorrhagic diathesis. Important preanalytical issues include prevention of prolonged venous stasis, 
order of drawing and appropriate filling of the collection tubes and careful mixing of blood with anticoagulant. 
Initial screening can be performed by global tests of haemostasis including viscoelastic testing using thrombelastography and ro-
tation thrombelastometry and/or a “basic examination profile” including platelet count, capillary bleeding time (optional in cases 
of suspected functional platelet disorders) and group tests prothrombin time (PT), activated partial thromboplastin time (APTT), 
and thrombin (clotting) time (optionally in cases of prolonged PT and APTT). This procedure allows a rational evaluation of the 
haemostatic system and a specific use of further tests including individual coagulation factor activities, inhibitor activities, activa-
tion markers, examination of von Willebrand factor, and platelet function analyses. It is important (1) to use species- and method 
specific reference values for interpretation and (2) to consider the limitations of tests when performed according to the standard 
test procedure optimised for human sample material (e.g., low sensitivity of PT test for canine and feline samples).   
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Adequate haemostasis depends on normal structure and function of the blood vascu-
lar system, platelet numbers and normal platelet 
function, and an adequate coagulation system. 
The vascular component can rarely be diagnosed 
as cause of haemostatic disorders, because stand-
ardised tests for vascular haemostatic dysfunction 
do not exist in veterinary medicine. In contrast, 
haemostatic disorders due to either quantitative 
and qualitative platelet defects or coagulation 
system disorders can be defined in detail by nu-
merous specific tests. 
A detailed history and a thorough clinical ex-
amination can deliver clues for an underlying haemo-
static disorder and its type (Hackner, 1995; Herring 
and McMichael, 2012). Bleeding patterns can indicate 
the cause of haemorrhage diathesis. Mucosal and cu-
taneous petechiae, purpura and ecchymoses are char-
acteristic findings in disorders of primary haemosta-
sis (thrombocytopenia, thrombocytopathia) (Figure 
1) (Botsch et al., 2009; Wondratschek et al., 2010; 
O`Marra et al., 2011). In contrast, blood coagulation 
disorders such as haemophilia are associated with 
ΠΕΡΙΛΗΨΗ
Στην ανασκόπηση αυτή αναφέρονται οι ενδείξεις για τον εργαστηριακό έλεγχο της αιμόστασης, η επιλογή των κατάλληλων για 
κάθε περίπτωση εξετάσεων, η μεθοδολογία για τη λήψη και το χειρισμό των δειγμάτων και η ερμηνεία των αποτελεσμάτων. Οι 
συνηθέστερες ενδείξεις για τον έλεγχο της αιμόστασης είναι η αιμορραγική διάθεση και η διάγνωση νοσημάτων που συνοδεύονται 
από διαταραχή της πήξης του αίματος. Σε αρκετές περιπτώσεις η ανασκόπηση του ιστορικού σε συνδυασμό με τα ευρήματα της 
κλινικής εξέτασης παρέχουν χρήσιμη πληροφόρηση για την αιτιολογία της αιμορραγικής διάθεσης. Κατά τη δειγματοληψία θα 
πρέπει να αποφεύγεται η παρατεταμένη ίσχαιμη περίδεση και να επιλέγονται τα φιαλίδια με το κατάλληλο αντιπηκτικό που θα 
γεμίζονται αυστηρά με την προκαθορισμένη κατά περίπτωση ποσότητα αίματος. Η ανάμιξη του αίματος με το αντιπηκτικό θα 
πρέπει να γίνεται με ήπιους χειρισμούς. Η εργαστηριακή αξιολόγηση της αιμόστασης περιλαμβάνει την μέτρηση του αριθμού 
των αιμοπεταλίων, του χρόνου ροής (προαιρετικά όταν υπάρχει υποψία θρομβοκυτταροπάθειας), του χρόνου προθρομβίνης (ΡΤ), 
του χρόνου ενεργοποιημένης μερικής θρομβοπλαστίνης (ΑΡΡΤ), του χρόνου πήξης (προαιρετικά, όταν οι ΡΤ και ΑΡΡΤ είναι 
αυξημένοι) και το θρομβοελαστόγραμμα. Η μεθοδική αυτή αξιολόγηση της αιμόστασης μπορεί να επεκταθεί με την εφαρμογή 
πιο εξειδικευμένων εξετάσεων όπως η μέτρηση των παραγόντων πήξης του αίματος, ο προσδιορισμός του παράγοντα von Wil-
lebrand και οι λειτουργικές δοκιμασίες των αιμοπεταλίων. Για την αξιοπιστία των ελέγχου της αιμόστασης θα πρέπει (1) να 
χρησιμοποιούνται μέθοδοι που έχουν αξιολογηθεί για εφαρμογή στο ζωικό είδος που εξετάζεται και (2) να λαμβάνονται υπόψη 
οι περιορισμοί που ισχύουν όταν εφαρμόζονται στα ζώα μέθοδοι που προορίζονται για τον άνθρωπο (για παράδειγμα, η μέθοδος 
μέτρησης του χρόνου προθρομβίνης στον άνθρωπο δεν είναι αρκετά ευαίσθητη για χρήση στο σκύλο και τη γάτα).
Λέξεις ευρετηρίασης: αιμοπετάλια, αιμόσταση,γάτα, θρομβοκυτταροπάθεια, παράγοντες πήξης αίματος, σκύλος,
Figure 1. Petechiae and ecchymoses in the pinna of a cat suffering 
from severe thrombocytopenia.
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larger areas of haemorrhage, e.g. subcutaneous or in-
tramuscular haematomas, body cavity and joint haem-
orrhages (Mischke, 2013) (Figure 2). Bleeding from 
mucosal surfaces (e.g., epistaxis, oral cavity haem-
orrhage, haematemesis, haematuria, haematochezia, 
melaena) can be associated with disorders of primary 
or secondary haemostasis. 
Global tests and/or a basic haemostasis examina-
tion profile with screening tests enable a rational as-
sessment of the haemostatic function and, in case of a 
haemostatic disorder, in many cases allow already to 
define its type or indicate specific tests necessary for 
final diagnosis (e.g., factor VIII and IX measurements 
for haemophilia diagnosis). 
IndIcAtIons FoR HAEMostAsIs tEstInG
Spontaneous bleeding (without detectable 
cause), bleeding disproportionate to degree of trauma 
Figure 2. Severe bleeding in the oral cavity and retropharyngeal 










table 1. Indications for laboratory evaluation of haemostasis in small animals
and bleeding from multiple sites are suspicious for 
haemostatic disorders and, therefore, are among the 




Haemostasis tests make higher demands on 
blood sampling techniques than most other param-
eters in the clinical laboratory (Lippi et al., 2012). For 
the measurements of platelet counts, k-EDTA blood 
is required. Blood coagulation tests are performed 
with plasma prepared from blood anticoagulated 
with sodium citrate or citrate buffer. For whole blood 
platelet aggregation studies (with the Multiplate ana-
lyser) hirudin-anticoagulated blood shows better 
results (kalbantner et al., 2010). 
sample tubes for citrated blood
To obtain citrated plasma, prefabricated sample 
containers are available from various manufacturers. 
The sample containers are prefilled with an adequate 
volume of 0.11 mol/l sodium citrate or citrate buffer 
solution to guarantee a mixture ratio of  9 parts of 
blood and one part of anticoagulant, when tubes are 
filled up to the graduation with blood. This results 
in a ratio between plasma and citrate solution of 
approximately 4.5 to 1 in a sample with normal 
haematocrit (e,g., 50 %). Underfilling of the vials 
by more than 10 % is critical, because human stud-
ies demonstrate that this leads to significantly pro-
longed coagulation times, especially of the activated 
partial thromboplastin time (APTT) (Reneke et al., 
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due to activation of clotting factors and/or platelets. 
The blood should flow carefully along the wall of 
the tube. If citrated blood is obtained with a syringe, 
aspiration should be carefully performed, since high 
vacuum can lead to activation of the coagulation 
system. Alternatively, samples for routine tests may 
be collected via an indwelling intravenous catheter 
(Maeckelbergh and Acierno, 2008), which, in dogs, 
results in acceptable agreement with values from 
blood samples collected via direct venipuncture. 
Use of samples collected via an intravenous catheter 
to monitor routine coagulation tests in critically ill 
patients eliminates additional venous trauma and 
discomfort and may also reduce the volume of blood 
getting lost during sample collection (Maeckelbergh 
and Acierno, 2008).
To guarantee intensive mixing of the collected 
blood with the anticoagulant (sodium citrate), tubes 
(or syringes) should be swayed carefully already 
while the blood is being collected. After the blood 
collection is finished, sample container must be care-
fully swayed and revolved several times. Haemolysis 
1998; Lippi et al., 2012).
Controlled over– or underfilling, respectively, of 
the tubes with blood may be indicated to achieve an 
adequate mixture ratio between the plasma content 
and citrate solution, when the haematocrit is mark-
edly increased or decreased (e. g., the ratio between 
plasma and citrate solution is approximately 2.25 to 
1 in a sample with a haematocrit of 75 %, whereas 
overfilling of the tube to approximately 190 % of the 
declared volume results in an adequate ratio).
blood collection
Blood collection should be carried out, if pos-
sible, without raising the vein or performing this 
only slightly and briefly (< 30 s) to avoid significant 
activation of the haemostatic and fibrinolytic sys-
tem (Lippi et al., 2012). A sharp disposable needle 
with an adequate lumen (e. g., 1.1x30 mm [19G] 
for dogs) should be used. The first drops of blood 
should be discarded or used for other sample tubes 
to avoid contamination of the samples with tissue 
factor, because this may result in misleading results 
table 2. Combined interpretation of test results from routine tests of haemostatic function and 
recommended further tests to differentiate between differential diagnoses
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1991). Based on these findings, shipment via over-
night express of citrated plasma to specialised labora-
tories seems possible and does not require cooling or 
freezing. However, the storage stability of coagulation 
proteins in citrated plasma has to be confirmed for 
pathological and feline sample material. In citrated 
whole blood from 40 dogs showing various diseases 
stored at room temperature (comment: procedure is 
not recommended, plasma should be separated as soon 
as possible, see above), median APTT decreased from 
14.2 s (baseline) to 12.6 and 12.0 sec after a storage 
time of 24 or 48 hours, respectively, possibly indicat-
ing pre-activation of the contact phase (Maunder et al., 
2012). This artificial shortening of APTT can mask 
mild factor deficiencies.
Platelet function is less stable and it is generally 
recommended to perform analyses (see below) within 
3–4 hours after sample collection. 
GLobAL tEstInG
Global tests assess the overall haemostatic func-
tion of a blood sample including the relationship 
between platelets and the coagulation system. These 
include simple tests such as the whole blood clotting 
time or the activated clotting time (ACT) (Bateman 
et al., 1999) and automatic viscoelastic point-of-care 
haemostatic assays, which undergo a revival (kol 
and Borjesson, 2010). These methods are easily to 
perform and can be used as bedside tests. Generally, 
these methods have limited sensitivity with respect 
to the detection of changes of individual haemostatic 
components. 
thrombelastography and thrombelastometry
The two currently leading point-of-care hae-
mostatic test systems are the thrombelastogra-
phy (TEG®) and rotation thrombelastometry 
(ROTEM®). Blood is collected in a cup heated at 37 
o C. Either native blood or recalcified citrated blood 
can serve as sample material, in each case without or 
with addition of activating agents (e.g., tissue factor, 
kaolin). A pin is suspended within the cup connected 
should be avoided (Lippi et al., 2012). In vitro addi-
tion of haemolysate significantly interferes with 
coagulation times such as APTT and (thrombin time) 
TT in canine plasma (Moreno and Ginel, 1999), 
although illustrations indicate only limited absolute 
effects and no clear concentration-dependency. In 
addition, studies on human sample material showed 
only negligible differences of prothrombin time (PT) 
and APTT between 50 paired haemolysed and recol-
lected non-haemolysed samples and between in vitro 
haemolysed samples and non-haemolysed controls 
(Laga et al., 2006), possibly making it unnecessary to 
reject haemolysed samples for routine tests.
citrated plasma preparation
Centrifugation of the sample and subsequent 
immediate removal of the (platelet-poor) citrated 
plasma supernatant using a pipette should be per-
formed as quickly as possible, at the latest within 
2 hours after blood collection. Immediately before 
centrifugation for 10 minutes at 1,500–2,000 x g, 
the sample should be checked for possible clots and 
coagulated samples must be discarded. 
storage stability, sample transport
Only minimal, mostly non-significant changes 
in routine coagulation tests (PT, APTT), vast major-
ity of the coagulation factors, antithrombin activity, 
and D-dimer concentration occur after storage of nor-
mal citrated plasma samples at room or refrigerator 
temperature for up to 48 hours (Furlanello et al., 
2006). After 24 hours, the only significant differ-
ence was a reduction of fibrinogen concentration in 
samples stored at 24 °C (mean values: initially 1.95 
g/l, after 24 hours: 1.87 g/l). These results contrast 
another storage study, where mean plasma fibrino-
gen concentration in normal canine plasma declined 
from initial mean values of 3.2 g/l to 2.9 g/l and 2.3 
g/l, respectively, after storage for 8 or 24 hours at 8 
°C (Piccione et al., 2010). Canine von Willebrand 
factor (vWf) in plasma stored at either 4°C or 22°C 
(and even in blood when stored at 22°C) is also rela-
tively stable for up to 48 hours (Johnstone et al., 
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bAsIc ExAMInAtIon pRoFILE
Basic examination profile for haemostasis usu-
ally includes platelet count, PT (syn.: thromboplastin 
time) and APTT. It may be expanded by thrombin 
(clotting) time and/or fibrinogen concentration meas-
urements when PT and APTT are prolonged, to 
further differentiate whether the final stage of blood 
coagulation (thrombin-fibrinogen-interaction, fibrin 
formation) is affected. Additional measurement of 
capillary bleeding time is indicated in cases where 
platelet dysfunction or von Willebrand`s disease are 
suspected.
platelet count
The platelet count can be estimated in a periph-
eral blood smear which, for example, can be used to 
verify thrombocytopenia measured by an automated 
blood cell counter. In addition, microscopic evaluation 
provides valuable information on platelet morphology 
(size, activation status, aggregates). Each platelet in an 
oil immersion lens field (1000 x total magnification) 
represents approximately 15 x 109 platelets/l (McCon-
nell, 2000). Thus, for example, a median of more than 
10 platelets/oil immersion field represents an adequate 
platelet count in dogs. Large platelets (shift platelets or 
megathrombocytes) may be seen in conditions in which 
there is excessive platelet destruction and a regenera-
tive platelet response with the exception of primary 
to a detector system (a torsion wire in the TEG and 
an optical detector in the ROTEM). The cup and pin 
are oscillated relative to each other through an angle 
of 4o 45’. The movement is initiated from either the 
cup (TEG) or the pin (ROTEM). When fibrin forms 
between the cup and pin, the transmitted rotation 
from the cup to pin (TEG) or the impedance of the 
rotation of the pin (ROTEM) are detected at the 
pin and registered as a graph. The different parts of 
the graph reflect different stages of the haemostatic 
process (clotting time, kinetics of fibrin formation, 
strength of the clot, and fibrinolysis). The nomencla-
ture is slightly different between TEG and ROTEM 
(Figure 3a).    
The method assesses the viscoelastic proper-
ties of clotting whole blood, reflecting interactions 
between cellular (platelets, erythrocytes, leukocytes) 
and plasmatic elements, and also of fibrinolysis 
under low shear conditions (kol and Borjesson, 
2010). Different haemostatic disorders are indicat-
ed by characteristic tracings (Figure 3b), whereas 
the automated numeric analysis of the graph is less 
important. Thereby, viscoelastic tests give an impres-
sion of the total haemostatic potential of a sample. In 
contrast to clotting tests, the method informs about 
the strength/stability of the clot and a possible lysis. 
It seems especially suited to detect hypercoagulable 
states (Wiinberg et al., 2008).
Figure 3. Schematic TEG/ROTEM traces indicating: (a) the commonly reported variables (1) reaction time (R)/clotting time (CT), (2) clot 
formation time (k/CFT), (3) alpha angle (α), (4) maximum amplitude (MA)/maximum clot firmness (MCF), and (5) lysis (Ly)/clot lysis 
(CL) as well as (b) different characteristic patterns: (A) normal, (B) hypercoagulability, (C) hypocoagulability (e.g. thrombocytopenia/
thrombocytopathia), (D) primary hyperfibrinolysis. 
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immune-mediated thrombocytopenia (Dircks et al., 
2009). They may also be seen in infiltrative diseases 
of the bone marrow and as a frequent breed variant in 
Cavalier king Charles Spaniels (Cowan et al., 2004) 
(Figure 4). Small platelets (microthrombocytosis) may 
be seen in iron deficiency anaemia.
Automated cell counters often provide inaccu-
rate platelet counts in cats because of the small size 
of red blood cells in cats and the tendency of feline 
platelets to form aggregates (Tasker et al., 2001) 
(Figure 5). Spurious thrombocytopenia occurs in 
Cavalier king Charles Spaniels, caused by the high 
frequency of large platelets. These dogs have usu-
ally a normal haemostatic function, which seems 
to be best reflected by plateletcrit determined by 
the IDEXX VetAutoread Hematology Analyzer 
(IDEXX Laboratories, Westbrook, USA) perform-
ing quantitative buffy coat analysis or by the Advia 
2120 Haematology system (Siemens Healthcare 
Diagnostics, Eschborn, Germany)  (Tvedten et al., 
2008, Tvedten et al., 2012). False counting can also 
occur if small or large platelets are not detected by 
the machine because of inappropriate machine set-
tings or calibration. Commercial kits (e.g., Thrombo-
Plus, Sarstedt, Nümbrecht, Germany) simplify visual 
platelet counting using a counting chamber (Figures 
6, 7). Healthy dogs have platelet counts of 150–500 
x 109/l and healthy cats of 180–550 x 109/l. Breed 
may have an influence (Lawrence et al., 2013) which 
is currently inappropriately considered. Usually 
platelet number must decrease below 60 x 109/l to 
cause a significantly increased bleeding risk.
Further tests to verify cause of thrombocytopenias
Thrombocytopenia is one of the most impor-
tant causes of haemorrhagic diathesis. Possible 
pathomechanisms include reduced production due 
to bone marrow diseases (e.g., hypoplasia, leukae-
mia, myelodysplasia) or increased turnover (loss, 
distribution abnormalities [splenomegaly, septicae-
mia] or consumption [immune-mediated, dissemi-
nated intravascular coagulation/DIC, vasculitis]). 
Various laboratory tests help to verify the underly-
Figure 4. Two large platelets (giant platelets) in the blood 
picture of a Cavalier king Charles spaniel suffering from 
macrothrombocytosis (Pappenheim stain, 2500x)
Figure 5. Platelet aggregates in the blood film of a cat indicated 
that automated platelet count (23,000/µl) was incorrect. Visual 
count revealed a true platelet count of 270,000/µl (Pappenheim 
stain, 1000x).
Figure 6. Test system for visual platelet counting: A capillary tube 
with 20 µl of EDTA blood is placed into a sample tube containing 
a haemolytic and dilution medium (Thrombo Plus™ system). 
The sample applicator stick (demonstrated on the left) which 
is attached to the lid of the sample tube can be used to load the 
haemocytometer by capillary action.
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normal platelet count and clotting tests. Furthermore, 
it is a useful pre-surgical screening test for ruling out 
defective primary haemostasis in an animal with no 
contemporary clinical evidence of bleeding. 
Capillary bleeding time in dogs is preferably 
measured in the non-anaesthetised dog in lateral 
position (Nolte et al., 1997). This method is, accord-
ing to the experience of the author, superior to the 
widely used buccal mucosal bleeding time (BMBT)
( Jergens et al., 1987) with regard to feasibility, pos-
sibility of standardisation, and safety purposes (i.e., 
possibility to stop bleeding with a bandage in case of 
a severe haemostatic disorder).
The skin of the lateral side of a front toe is shaved 
and a hyperaemic agent is applied for 1 minute to the 
shaved area and wiped off (Figure 9). A sphygmoma-
nometer cuff, which was earlier placed above the 
antebrachium, is pumped up to apply a pressure of 60 
mm Hg. This is performed to increase and standard-
ise blood flow in the puncture area. One minute after 
applying the pressure of 60 mm Hg, the skin is punc-
tured twice 5 mm apart, with a sterile manual or semi-
automatic blood lancet, close to the edge of the horny 
skin of the pad (Figure 10). The blood is carefully 
dabbed off every 15 seconds with a swab until the 
bleeding stops (i.e., until there are no traces of blood 
ing pathomechanism and disease. Bone marrow 
examination does not only assess thrombopoietic 
activity (reference values in adult female dogs: 10.4 
+/- 2.67 platelet percursors per low power field and 
in male dogs: 7.84 +/- 2.04, P = 0.0008) (Mischke 
et al., 2002), but may also offer further clues on 
the underlying disease (Figure 8). Increased mean 
platelet volume can indicate increased thrombopoi-
etic activity, but may be low in primary immune-
mediated thrombocytopenia despite high throm-
bopoietic activity (Dircks et al., 2009). Reticulated 
platelets are an alternative parameter of throm-
bopoietic activity. Flow cytometric detection of 
platelet-associated antibodies is helpful, but this test 
does not differentiate between primary and the more 
frequently occurring secondary immune-mediated 
thrombocytopenias (Dircks et al., 2009). 
capillary bleeding time 
The (capillary) bleeding time is the time until 
a standardised capillary bleeding ceases and a use-
ful in vivo screening test for the function of primary 
haemostasis. It is indicated in patients with suspected 
platelet function disorder or von Willebrand`s dis-
ease, i.e. in patients with haemorrhagic diathesis with 
Figure 8. Significantly increased number of platelet precursors 
(partly indicated by arrows) in the bone marrow aspirate of a dog 
with severe thrombocytopenia (20,000/µl) indicates an underlying 
immune-mediated pathomechanism (Pappenheim stain, 100x).
Figure 7. In the counting chamber, platelets are detected as small 
dots with a light centre and must be differentiated from the larger 
white blood cells (in the middle of the right hand side, two white 
blood cells can be seen; cell shadows in the background represent 
lysed red blood cells).  
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with extremely prolonged haemorrhage from punc-
ture sites and may require application of a bandage.
blood coagulation tests (global tests, group tests)
Coagulation tests measure the time taken for cit-
rated platelet-poor plasma to clot when coagulation 
is initiated by the addition of calcium and activating 
agents. Blood coagulation tests are usually performed 
with coagulometric methods, but can also be per-
formed with chromogenic assays. Coagulation times 
can be measured by manual techniques (tilt tube, 
hook technique) with visual detection of the time 
point of clot formation, but these techniques require 
considerable practice to obtain reliable results. 
Preferably, semi-automated or automated coagulom-
eters are used, which are based on different electro-
mechanical (e.g., Schnitger and Gross coagulometer 
based on the hook technique, ball coagulometer) or 
photo-optical techniques which detect a change in the 
intensity of light transmission when clot formation 
occurs. In addition, point-of-care analysers with test 
cartridges for PT and APTT are available for animals 
(e.g., VetScan VSpro Coagulation Analyzer; Abaxis 
Europe, Darmstadt, Germany). A recent study dem-
onstrated an acceptable correlation with conventional 
PT and APTT assays (Dixon-Jimenez et al., 2013).
In order to test the plasmatic coagulation sys-
tem rationally, the screening tests PT and APTT are 
widely used. These tests evaluate the whole plasma 
coagulation system with the exception of factor-
XIII-dependent fibrin cross-linking (Figure 11). Each 
of these “group tests” records several coagulation 
factors of the extrinsic and common or intrinsic and 
common pathway, respectively. When PT and aPTT 
are prolonged, the complementary measurement of 
the thrombin time, the third group test, is indicated. 
Measurements of these parameters in canine and 
feline plasma are typically performed using tests 
optimised for the determination of human plasma, 
but species specific features suggest test modifica-
tions and/or must be considered when interpreting 
test results.  
noticeable on the swab). The average time from the 
two punctures is calculated as capillary bleeding time.
The reference values of this method in the dog 
are 1–2.5 minutes. The reference ranges for the 
BMBT in dogs are 1.7–4.2 minutes (Jergens et al., 
1987) and in cats 1.0–2.4 minutes (Parker et al., 
1988). Result depends significantly on the device 
(Aumann et al., 2013). Prolonged capillary bleeding 
times can be caused by severe thrombocytopenia, 
platelet function disorders or von Willebrand`s dis-
ease. In patients with normal platelet count, capillary 
bleeding time serves as a screening test of platelet 
function disorders and von Willebrand`s disease. 
Severe von Willebrand`s disease can be associated 
Figure 9. Capillary bleeding time: A non-anaesthetised dog is held 
in lateral recumbency and a hyperaemic agent is applied to the 
shaved lateral side of a front toe. 
Figure 10. A blood lancet is used to make two punctures close to 
the edge of the keratinized skin of the footpad.  The bleeding time 
is detected by carefully dabbing the blood from these two sites 
every 15 sec with a swab until the bleeding stops. 
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thromboplastins seem better activators of animal 
samples than synthetic/recombinant human thrombo-
plastins. High inter-batch stability indicates that the 
preparation of lot-specific references is not required. 
Calculation of percentage activity values or PT ratios 
may minimise differences between different lots of 
one defined reagent, if an adequate and consistent 
standard material is available. However, even after 
converting the result into a prothrombin ratio or 
in percent of normal activity (compared to a refer-
ence curve prepared with a canine or feline pooled 
plasma), it is impossible to get a reagent-independent 
result (Mischke, 2010).
Prolongation of the PT standard test indicates a 
severe deficiency in clotting factors, because factors 
must decrease to less than 30% of normal to cause 
prolongation of PT, whereas the optimised test can 
also detect milder factor deficiencies. The PT is fre-
quently prolonged in acquired vitamin k deficiency, 
liver disease, specific factor deficiencies and DIC. 
Factor VII deficiency causes prolongation of the PT 
with no change in APTT and thrombin time. Due to 
the short half-life of factor VII, the PT is selectively 
prolonged in the early stages of acquired vitamin k 
deficiency.
Activated partial thromboplastin time
APTT imitates coagulation activation via the 
contact phase and identifies coagulation factor abnor-
malities of the intrinsic (high-molecular weight 
kininogen, prekallikrein, factors XII, XI, IX and 
VIII) and common pathway (factors X, V, II, and 
fibrinogen). 
Clotting is initiated by adding a surface activator 
(such as ellagic acid, silica or kaolin), phospholipid 
(which substitutes the negatively charged phospholi-
pid surface provided by platelets in vivo), and excess 
calcium. The reagents used in the APTT vary greatly 
in composition and therefore in sensitivity and spe-
cificity. Dilution of the plasma does not increase 
the sensitivity of this test when using electro-optical 
detection of fibrin formation (Johnstone, 1984).
With sensitive APTT reagents (e.g. Hemos IL 
SynthAFAX, Instrumentation Laboratory, Bedford, 
Prothrombin time
Prothrombin time imitates the coagulation acti-
vation via the extrinsic pathway and measures the 
coagulation factors of the extrinsic and common 
pathway. Clotting is initiated by adding calcium and 
tissue thromboplastin, which provides tissue factor 
and substitutes the negatively charged phospholipid 
surface provided by platelets in vivo.
Prothrombin time measured in canine or feline 
plasma following the manufacturers` test instruc-
tions (“PT standard test”) is significantly shorter 
than in human beings and, consequently, insensitive 
for indicating decreased coagulation factor activ-
ity. In specialised laboratories, the use of an opti-
mised test (e.g., 100 µl 1:20 diluted sample, 100 
µl fibrinogen solution [to guarantee an adequate 
fibrin clot formation], incubation for 2 minutes, 100 
µl Ca-thromboplastin reagent) is preferable to the 
standard test for use in dogs and cats (Mischke et 
al., 1996; Mischke and Nolte, 1997). Apart from the 
modified test, commercial PT test modifications such 
as Hepato Quick or Normotest are suitable screen-
ing tests of the extrinsic system in dogs and cats 
(Mischke, 2002).
In general, reagents based on animal-derived 
Figure 11. Classical presentation of the haemostasis system 
indicating areas examined by the three group tests prothrombin 
time (PT), activated partial thromboplastin time (APTT), and 
thrombin time (TT).
Abbreviations: F – (coagulation) factor; HMWk – high molecular 
weight kininogen; PL – phospholipid; Ca – Calcium ions.
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interpretation of results of group tests and also of 
other haemostasis test procedures. These reference 
values are best established in the laboratory itself and 
should be based on a sufficient number of healthy 
animals of the respective species (at least 40). 
Interpretation of test results of the basic 
programme
Combined interpretation of results from plate-
let count and group tests and, if necessary, capillary 
bleeding time, often allows a tentative diagnosis to 
be made, which partially needs confirmation or fur-
ther differentiation by further tests, especially indi-
vidual factor analyses (Tab. 1). 
FuRtHER And spEcIFIc  tEsts
In individual cases, additional specific tests are 
necessary to confirm diagnosis or to accompany 
therapy. 
blood clotting factors
Determination of plasma activities of individual 
clotting factors is important for the diagnosis and 
monitoring of haemostatic disorders, particularly 
hereditary individual clotting factor deficiencies such 
as haemophilia A and B. Factors II, V, VII, and X 
are measured with a modified PT test, factors VIII, 
IX, XI, and XII with a modified APTT. The tests 
are performed with a diluted sample and addition of 
a deficient plasma that is deficient in a single indi-
vidual factor. Therefore, the coagulation time of the 
test depends on the residual activity of the requested 
coagulation factor.
Coagulometric tests that incorporate human 
deficient plasma are typically used for the determina-
tion of clotting factor activities in dogs and cats. Due 
to the fact that particularly factor V and VIII:C activ-
ities in canine and feline plasma are several times as 
high as in human plasma, accurate measurement of 
coagulation factor activities in canine or feline plas-
ma, using human deficient plasma, requires higher 
sample dilution (i.e., 1:>20) than typically used for 
USA), APTT test optimised for human plasma 
can even detect mild individual factor deficien-
cies in canine and feline plasma (Mischke, 2000). 
Haemophiliacs have usually prolonged APTTs, dogs 
with haemophilia A of approx. 1.5 to 2.5-times nor-
mal. With less sensitive reagents even significant fac-
tor deficiencies to values < 30 % may result in false 
negative (normal) results. Haemophilic carriers with 
residual activities of usually 40–60 % factor VIII 
or IX can not be detected with sufficient certainty. 
Optimal APTT ratio for heparin treatment (i.e., cor-
responding to 0.3 to 0.7 I.U./ml) must be assessed 
by APTT-reagent and heparin-preparation specific 
calibration.   
Thrombin time (thrombin clotting time)
Thrombin time measurements are indicated in 
cases of combined prolongation of PT and APTT to 
assess, whether the final fibrin generation process 
is involved in the haemostatic disorder. In addition, 
thrombin time is used to control heparin therapy. 
Thrombin time measures the clotting time of cit-
rated plasma after the addition of exogenous thrombin. 
The result depends on the availability of an adequate 
concentration of fibrinogen and possible inhibitors of 
thrombin-fibrinogen-interaction (heparin) and fibrin 
polymerisation (fibrin[ogen] degradation products, 
abnormal serum proteins).
Commercial test kits are suitable to measure 
thrombin time in dogs and cats. Thrombin time in 
dogs and cats gives very similar results to humans. 
The thrombin time is prolonged, if the fibrino-
gen concentration is less than 0.7 g/l. In sam-
ples containing a normal fibrinogen concentration, 
fibrinogen degradation products cause prolongation 
at concentrations of ≥ 0.1 mg/ml (Mischke and 
Wolling, 2000). High thrombin concentrations are 
required to monitor animals receiving therapeu-
tic doses of unfractionated heparin (Mischke and 
Jacobs, 2001).  
Reference values
The use of animal species-, method-, and rea-
gent-specific reference values is important for the 
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Canine and feline pool plasmas are ideal standards. 
Subnormal AT levels (< 75 %) are associated with 
decreased heparin effectiveness. AT concentrations 
decrease in DIC. In one study, 85% of dogs (35 of 
41) with confirmed DIC had decreased AT levels 
(Feldman et al., 1981). AT also decreases in hepatic 
disease owing to decreased synthesis. AT is similar 
in size to albumin and is lost in protein-losing neph-
ropathies and protein-losing enteropathies.
Activation markers
Plasma markers which are useful to detect an 
activation of the clotting system in small animals 
(e.g. thrombosis, DIC) include D-dimer, soluble fibrin 
and thrombin-antithrombin complex concentrations. 
Because antibodies against human D-dimers cross-
react with canine and feline D-dimers, human tests 
are suitable. Immunoturbidimetric methods are use-
ful reference methods (Boutet et al., 2009). Point of 
care cartridge tests are available and partly evaluated 
for canine samples (e.g., NycoCard D-dimer test and 
Nyco-Card READER II, Axis-Shield Point-of-Care 
Division, Oslo, Norvay) (Dewhurst et al., 2008). 
Healthy dogs have D-dimer concentrations of 
less than 0.25 µg/ml. Because generation of D-dimers 
requires actions of thrombin and plasmin, increased 
D-dimers are markers of intravascular clotting. A neg-
ative result more or less rules out thrombosis, but a 
positive result is relatively unspecific (Nelson and An-
dreasen, 2003). Many DIC scores include increased 
D-dimer levels.
Von Willebrand`s disease 
Von Willebrand diagnostics is indicated especial-
ly in animals with prolonged bleeding time that cannot 
be explained elsewhere (especially by thrombocytope-
nia).  Furthermore, measurements of vWF is indicated 
in cases with suspected haemorrhagic disorder, which 
cannot be captured by measurement results of platelet 
count and clotting tests. In most cases, measurements 
of vWF concentration is adequate. This can be per-
formed with human test kits based on latex agglutina-
tion or ELISA test principles due to cross-reactivity 
human plasma (Mischke, 2001). 
Differences in activities between human and 
canine or feline plasma and non-parallelism of the 
standard curves emphasize the necessity of use of 
species-specific standard curves for accurate determi-
nation of clotting factor activity. Standard curves are 
prepared with different dilutions of species-specific 
pooled plasma whose activity is usually defined as 
100 %. Factor activities of 30 % are usually suf-
ficient for a physiological haemostatic function. 
Haemophilic patients have usually < 10 % of the 
respective coagulation factor.
The fibrinogen concentration is usually deter-
mined in an extended coagulation profile and also 
with regard to its role as an acute phase reactant, 
mostly using the functional clotting method accord-
ing to Clauss (Ameri et al., 2011). Commercially 
available standard curves for human fibrinogen or 
human standard material can be used for calibration, 
because calibration curves prepared with canine or 
feline specific fibrinogen standards show very similar 
results. The fibrinogen concentration ranges from 1.0 
to 3.0 g/l in normal dogs and cats. Hyperfibrinolysis 
occurs frequently including animals with DIC. 
Hypofibrinogenaemia occurs primarily because of 
increased fibrinolysis in DIC with dominant hyperfi-
brinolysis.
Inhibitors
The most important inhibitors of the blood clot-
ting system are antithrombin (AT) and protein C. 
Antithrombin measurement is particularly necessary 
in cases of DIC receiving high dose heparin treat-
ment to guarantee an adequate AT level. Heparin 
mainly functions by enhancing the inhibition of 
thrombin by AT and, thereby, increases AT con-
sumption. Assessment of AT activity is also useful in 
animals suspected of having a hypercoagulable state. 
Common assays for AT activity are based on syn-
thetic factor Xa- or thrombin-dependent chromogenic 
substrates and well suited for measurement of anti-
thrombin activitiy in animals (Mandell et al., 1991). 
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monoclonal gammopathy)  and after application of 
anti-platelet agents (aspirin, clopidogrel) and other 
drugs (NSAIDs, dextran, antibiotics).
Platelet function analyser (PFA 100)
The platelet function analyser PFA-100 
(Siemens Healthcare Diagnostics, Germany) has 
been evaluated and is suitable for use in dogs (Callan 
and Giger, 2001; Mischke and keidel, 2003). The 
instrument comprises a microprocessor-controlled 
instrument and disposable test cartridges contain-
ing a biologically active membrane. The instrument 
aspirates a blood volume under constant vacuum 
from a sample reservoir in the test cartridge through 
a capillary and a microscopic aperture cut into the 
membrane at the end of the capillary (Figure 12). 
The membrane is coated with collagen and adenosine 
diphosphate (collagen/ADP cartridge) or collagen 
and epinephrine (adrenaline) (collagen/epinephrine 
cartridge). The presence of these biochemical stimu-
li, and the high shear rates developed under standard-
ized flow conditions, result in platelet attachment, 
activation, aggregation, and slow formation of a sta-
ble platelet plug at the aperture. The “closure time” is 
reported by the analyser. 
The analysis should be performed between 30 
min and 2 h after collection of the citrate buffer-
anticoagulated blood which is the standard sample 
material (Mischke and keidel, 2002). It is advisable to 
use only one position, e.g. position A, of the two alter-
native measuring positions of the analyser, because 
spontaneous sedimentation can lead to artificial results 
in the second cartridge inserted into position B. 
Reference values are as follows: collagen/
ADP cartridge: 52–86 s (Callan and Giger, 2001), 
53–98 s (Mischke and keidel, 2003); collagen/epine-
phrine cartridge: 97–225 s (Callan and Giger, 2001), 
92–>300 s (Mischke and keidel, 2003).
The method can be regarded as a global screen-
ing test of primary haemostasis. Apart from platelet 
function, the result is significantly influenced by 
platelet count and haematocrit (Callan and Giger, 
2001; Mischke and keidel, 2003). Unfortunately, 
of the antibodies. Specific assays (collagen binding 
assays, electrophoretic multimeric analysis) detect a 
selective loss of the functionally active large multim-
ers to characterize a Type II von Willebrand`s disease 
(Burgess and Woods, 2008).
Canine pooled plasma serves as the standard. 
VWF has a wide reference range (50–180 %). It is 
an acute phase reactant and may be increased in con-
ditions such as strenuous exercise, age, azotaemia, 
liver disease, parturition and after application of the 
vasopressin analogue, 1-desamino-8-d-arginine vaso-
pressin (DDAVP).
platelet function analysis
In cases of prolonged capillary bleeding time 
despite normal platelet count and exclusion of von 
Willebrand`s disease, functional platelet tests can 
provide further information with respect to the under-
lying cause. Further indications exist in patients suf-
fering from primary diseases frequently associated 
with platelet functional disorders (e.g., liver disease) 
or for monitoring and evaluation of anti-platelet drug 
treatment. Finally, global tests of primary haemos-
tasis such as capillary bleeding time and automated 
platelet function analysis are indicated for the estima-
tion of the overall function of primary haemostasis in 
thrombocytopenic dogs requiring surgeries. To char-
acterise functional platelet disorders, a wide variety 
of platelet function tests is available which, unfor-
tunately, often lack standardisation. Apart from the 
“global tests” cited above these include, for exam-
ple, platelet aggregation, flow cytometric analyses, 
thromboelastography (esp. “TEG platelet mapping” 
which is performed with special reagents) (Brainard 
et al., 2010) and thrombelastometry as well as mean 
platelet component. 
Whereas primary functional abnormalities of 
platelets (e.g., Glanzmann`s thrombasthenia; signal-
ling defects, storage pool deficiency, and Chediak-
Higashi syndrome) are extremely rare in animals 
(Boudreaux, 2008) and in humans, acquired platelet 
dysfunctions are more frequent and occur associated 
with many diseases and disorders (e.g. hepatopathy, 
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the turbidimetric method has the advantage that the 
platelet count can be adjusted to a defined value, the 
preparation of platelet-rich plasma requires addition-
al equipment and time, large sample volumes, and 
experienced personnel. This preparation procedure 
can also alter the quality of the sample through loss 
of large platelets with increased or decreased reac-
tivity. Impedance aggregometry on whole blood can 
more effectively evaluate lipaemic samples. It may 
also better reflect in vivo platelet functionality, given 
that platelets can interact with other blood cells. The 
electrical probes of the impedance method create an 
artificial surface and therefore may better mimic in 
vivo platelet aggregation which typically occurs on 
injured or inflamed vascular surfaces.
The novel impedance aggregometer Multiplate 
Analyser (Roche Diagnostics GmbH GmbH, 
Mannheim, Germany) seems to be well suited for 
use in dogs (kalbantner et al., 2010). The test can 
be performed as recommended by the manufacturer 
for human sample material (300 µl isotonic sodium 
chloride solution, 300 µL of hirudin-anticoagulated 
blood, 3 min incubation and stirring at 37°C, addition 
of 20 µL agonist solution) (kalbantner et al., 2010). 
The impedance change caused by the adhesion and 
aggregation of platelets on the electrodes is continu-
ously detected. 
To achieve optimal sensitivity, minimum effec-
tive (threshold) concentrations of agonists should be 
used which reliably induce high maximum aggre-
gation values in healthy animals. In a canine study 
using the Born method, the following threshold con-
centrations (final test concentrations) were estab-
lished: 25 µmol/l adenosine diphosphate (ADP), 
10 µg/ml collagen and 1 IU/ml thrombin (Mischke 
and Schulze, 2004). In an actual study using the 
Multiplate instrument, the following optimal agonist 
concentrations (sourced from Roche Diagnostics 
GmbH) were defined: 10 µmol/l ADP, 5 µg/ml col-
lagen, and 1 mmol/l arachidonic acid (kalbantner et 
al., 2010). Reference values should be established 
method- and laboratory-specific. Platelet aggregation 
is particularly suitable to detect decreased platelet 
even slightly subnormal haematocrit values are asso-
ciated with a prolongation of the closure time which 
limits the clinical applicability of the analyser. 
Because measurements using the collagen/epine-
phrine cartridge exceed upper limit of the measuring 
range already in a small percentage of healthy dogs 
(Mischke and keidel, 2003), this cartridge type is 
less suitable for tests of primary platelet function in 
dogs. 
Platelet aggregation
The measurement of platelet aggregation is one 
of the most important in vitro methods of assessing 
platelet function. There are two main measurement 
principles of in vitro platelet aggregation following 
the addition of agonists. The turbidimetric method 
measures the increase of light transmission in plate-
let-rich plasma during aggregation, while impedance 
aggregometry measures the increase in the electrical 
resistance in blood resulting from platelet accumula-
tion (Dyszkiewicz-korpanty et al., 2005). Although 
Figure 12. Schematic diagram of the cross-sectional view of the 
functional unit of the platelet function analyser PFA-100.
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function. Because low agonist concentrations are 
associated with a wide range of results, it is almost 
impossible to detect hyperaggregability in individual 
patients. Platelet counts influence the result.
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